APA (7th ed.) Citation

K, C., J, Y., K, H., L, D., PS, A., R, B., . . . TY, L. (2023). Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials. Molecular therapy : the journal of the American Society of Gene Therapy, 31(3), 801. https://doi.org/10.1016/j.ymthe.2022.12.006

Chicago Style (17th ed.) Citation

K, Cornetta, et al. "Replication Competent Retrovirus Testing (RCR) in the National Gene Vector Biorepository: No Evidence of RCR in 1,595 Post-treatment Peripheral Blood Samples Obtained from 60 Clinical Trials." Molecular Therapy : The Journal of the American Society of Gene Therapy 31, no. 3 (2023): 801. https://doi.org/10.1016/j.ymthe.2022.12.006.

MLA (9th ed.) Citation

K, Cornetta, et al. "Replication Competent Retrovirus Testing (RCR) in the National Gene Vector Biorepository: No Evidence of RCR in 1,595 Post-treatment Peripheral Blood Samples Obtained from 60 Clinical Trials." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 31, no. 3, 2023, p. 801, https://doi.org/10.1016/j.ymthe.2022.12.006.